Search for Clinical Trial Results

Sponsored By

Glucagonoma - 50 Studies Found

Status Study
Withdrawn Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2014-01-07
    Interventions:
    • Drug: dovitinib lactate Given

Active, not recruiting Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Condition:
  • Adult Hepatocellular Carcinoma
  • Advanced Adult Hepatocellular Carcinoma
  • Biological: Bevacizumab Given

Recruiting Study Name: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2014-10-03
    Interventions:
    • Drug: regorafenib Given PO
Terminated Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2014-01-07
    Interventions:
    • Drug: everolimus Given PO
Active, not recruiting Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2013-04-02
    Interventions:
    • Drug: temozolomide Given PO
Active, not recruiting Study Name: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2012-01-10
    Interventions:
    • Drug: capecitabine Given PO
Active, not recruiting Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2008-04-09
    Interventions:
    • Drug: everolimus Given orally
Completed Study Name: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2005-08-16
    Interventions: Drug: sorafenib tosylate 400 mg given orally Other N
Terminated Study Name: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2004-06-10
    Interventions:
    • Drug: romidepsin Given IV
Completed Study Name: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insuli
    Date: 2004-01-09
    Interventions:
    • Drug: gefitinib Given orally
Next >>>